Eylea 40 mg (Aflibercept 40 mg/ml) by Bayer.
Indications: Neovascular (wet) age-related macular degeneration, macular oedema secondary to retinal vein occlusion, diabetic macular oedema and myopic CNV.
Administration: Intravitreal injection by a qualified ophthalmologist under aseptic conditions.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Bayer / Regeneron |
| Active ingredient | Aflibercept 40 mg/ml — VEGF-trap fusion protein; each intravitreal dose 2 mg / 0.05 ml. |
| Strength & pack | 1 vial or pre-filled syringe. |
| Form | Solution for intravitreal injection |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |